Purple Innovation, a maker of polymer gel mattresses, adopted a poison pill in response to Coliseum Capital Management's unsolicited $4.35-per-share takeover offer, the company said.
Why it matters: The offer comes as mattress companies have begun to see a slowdown in overall demand against a difficult macroeconomic environment.
